Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).

PubWeight™: 2.86‹?› | Rank: Top 1%

🔗 View Article (PMID 12830453)

Published in Am J Kidney Dis on July 01, 2003

Authors

Wendy Weinstock Brown1, Rosalind M Peters, Suzanne E Ohmit, William F Keane, Allan Collins, Shu-Chen Chen, Karren King, Michael J Klag, Donald A Molony, John M Flack

Author Affiliations

1: Division of Nephrology, St Louis VA Medical Center, St Louis University School of Medicine, St Louis 63106-1621, USA. wendy.brown@med.va.gov

Articles citing this

Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health (2008) 4.49

Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol (2008) 2.41

Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ (2006) 2.29

Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol (2009) 2.24

Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24

White/black racial differences in risk of end-stage renal disease and death. Am J Med (2009) 2.16

Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int (2011) 1.87

Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol (2013) 1.67

The burden of chronic kidney disease. BMJ (2006) 1.57

No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney Int (2013) 1.38

Prevalence and awareness of CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis (2009) 1.37

Prevalence of anemia in chronic kidney disease in the United States. PLoS One (2014) 1.33

Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and Modification of Diet in Renal Disease equation: an observational, cross-sectional study. BMC Nephrol (2009) 1.33

High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol (2009) 1.29

Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2013) 1.29

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol (2008) 1.19

Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.18

Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP). Clin J Am Soc Nephrol (2011) 1.13

Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 1.09

Hypertension: what's sex got to do with it? Physiology (Bethesda) (2013) 1.09

Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study. BMC Nephrol (2009) 1.08

Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis (2011) 1.04

Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2012) 1.01

Associations between access to care and awareness of CKD. Am J Kidney Dis (2012) 1.00

Access to health care among adults evaluated for CKD: findings from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2012) 0.99

Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep (2011) 0.98

The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97

Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study. BMC Nephrol (2011) 0.95

Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program. Cardiorenal Med (2011) 0.93

Risk factors associated with disease progression and mortality in chronic kidney disease of uncertain etiology: a cohort study in Medawachchiya, Sri Lanka. Environ Health Prev Med (2011) 0.93

Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants. Am J Kidney Dis (2012) 0.92

Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol (2008) 0.92

Barriers facing patients referred for kidney transplant cause loss to follow-up. Kidney Int (2012) 0.91

The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2013) 0.90

Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran. PLoS One (2010) 0.90

Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population. Int J Nephrol (2012) 0.89

Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program. Am J Nephrol (2008) 0.88

Routine screening for CKD should be done in asymptomatic adults... selectively. Clin J Am Soc Nephrol (2014) 0.86

The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease. Cardiorenal Med (2011) 0.85

The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program. J Clin Endocrinol Metab (2012) 0.84

A survey of kidney disease and risk-factor information on the World Wide Web. MedGenMed (2004) 0.84

The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system. Diab Vasc Dis Res (2014) 0.84

The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program. Cardiorenal Med (2013) 0.82

Effects of proactive population-based nephrologist oversight on progression of chronic kidney disease: a retrospective control analysis. BMC Health Serv Res (2012) 0.82

Chronic Kidney Disease : The Looming Threat. Med J Armed Forces India (2011) 0.82

The See Kidney Disease Targeted Screening Program for CKD. Clin J Am Soc Nephrol (2016) 0.81

Prevalence of Early Stages of Chronic Kidney Disease in Healthy Army Personnel. Med J Armed Forces India (2011) 0.81

Albuminuria among Alaska Natives--findings from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Nephron Clin Pract (2010) 0.80

Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease. Cardiol Res Pract (2010) 0.80

Health care provider perception of chronic kidney disease: knowledge and behavior among African American patients. BMC Nephrol (2014) 0.80

Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP). BMC Nephrol (2012) 0.78

Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants. Clin J Am Soc Nephrol (2015) 0.78

Epidemiology of chronic kidney disease, with special emphasis on chronic kidney disease of uncertain etiology, in the north central region of Sri Lanka. J Epidemiol (2015) 0.77

Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup. Clin Exp Nephrol (2011) 0.77

Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China. BMC Nephrol (2013) 0.76

Health-Risk Factors and the Prevalence of Chronic Kidney Disease: Cross-Sectional Findings from a National Cohort of 87,143 Thai Open University Students. Glob J Health Sci (2015) 0.76

A Case for Early Screening for Diabetic Kidney Disease. Cardiorenal Med (2011) 0.76

The prevalence of chronic kidney disease in apparently healthy retired subjects in asaba, Nigeria. Ann Med Health Sci Res (2014) 0.75

Positive Predictive Value of a Single Assessment of Estimated GFR in the Diagnosis of Chronic Kidney Disease. South Med J (2016) 0.75

Validation of an Albuminuria Self-assessment Tool in the Multi-Ethnic Study of Atherosclerosis. Ethn Dis (2015) 0.75

Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients. Int J Mol Sci (2016) 0.75

Early diagnosis saves lives: focus on patients with chronic kidney disease. Kidney Int Suppl (2011) (2013) 0.75

Articles by these authors

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22

Major causes of death among men and women in China. N Engl J Med (2005) 11.80

MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension (2003) 6.01

The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33

Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med (2014) 5.31

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis (2004) 4.82

Mortality attributable to smoking in China. N Engl J Med (2009) 4.75

Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol (2012) 4.56

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA (2004) 4.54

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int (2004) 4.51

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med (2003) 4.08

Nephropathy in diabetes. Diabetes Care (2004) 4.08

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation (2004) 3.78

Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med (2009) 3.49

Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol (2003) 2.95

Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis (2012) 2.91

Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82

Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med (2005) 2.82

Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol (2005) 2.74

Physical functioning, depression, and preferences for treatment at the end of life: the Johns Hopkins Precursors Study. J Am Geriatr Soc (2004) 2.64

Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet (2009) 2.62

Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol (2007) 2.61

Global health is public health. Lancet (2010) 2.59

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol (2002) 2.58

Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol (2006) 2.56

Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis (2004) 2.48

The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol (2009) 2.41

Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion. PLoS Genet (2005) 2.33

Anger in young men and subsequent premature cardiovascular disease: the precursors study. Arch Intern Med (2002) 2.33

Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J Clin Invest (2007) 2.24

Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol (2006) 2.23

Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis (2011) 2.19

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14

Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med (2008) 2.11

Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int (2004) 2.10

Changes in serum potassium mediate thiazide-induced diabetes. Hypertension (2008) 2.09

Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol (2004) 1.97

Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One (2011) 1.94

Diabetic nephropathy. Diabetes Care (2003) 1.87

The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int (2008) 1.83

Effects of perceived racism, cultural mistrust and trust in providers on satisfaction with care. J Natl Med Assoc (2006) 1.82

Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet (2009) 1.81

Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79

Alcohol consumption and risk for stroke among Chinese men. Ann Neurol (2007) 1.79

Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71

Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension (2004) 1.67

Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66

Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol (2002) 1.61

Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61

Subclinical hypertensive heart disease in black patients with elevated blood pressure in an inner-city emergency department. Ann Emerg Med (2012) 1.54

The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens (2002) 1.54

Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. Am J Transplant (2005) 1.53

Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int (2003) 1.50

Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int (2004) 1.48

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study. Clin Exp Nephrol (2006) 1.46

Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int (2005) 1.45

Prospective association between hypotension and idiopathic chronic fatigue. J Hypertens (2004) 1.45

Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis (2003) 1.45

Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. MMWR Morb Mortal Wkly Rep (2014) 1.44

Association of childhood socioeconomic status with subsequent coronary heart disease in physicians. Arch Intern Med (2006) 1.44

Sports ability in young men and the incidence of cardiovascular disease. Am J Med (2002) 1.39

Effects of nurse-managed telemonitoring on blood pressure at 12-month follow-up among urban African Americans. Nurs Res (2007) 1.30

High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. J Am Soc Nephrol (2005) 1.29

A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol (2007) 1.27

Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis (2005) 1.26

Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. Stroke (2002) 1.25

Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology (Carlton) (2004) 1.21

The Metabolic Syndrome in African Americans: a review. Ethn Dis (2003) 1.20

The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol (2003) 1.20

Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis (2011) 1.19

Life-sustaining treatments: what do physicians want and do they express their wishes to others? J Am Geriatr Soc (2003) 1.18

Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney Int (2005) 1.18

Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.18

Body mass index and risk of incident hypertension over the life course: the Johns Hopkins Precursors Study. Circulation (2012) 1.17

The case for diversity in academic internal medicine. Am J Med (2004) 1.16

Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race. J Am Soc Nephrol (2005) 1.16

Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program. Kidney Int Suppl (2003) 1.15

Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis (2007) 1.12

Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation. Diabetes Care (2003) 1.12

Achieving diversity in academic internal medicine: recommendations for leaders. Am J Med (2006) 1.10

Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients. J Am Soc Nephrol (2004) 1.09

Blood pressure change and risk of hypertension associated with parental hypertension: the Johns Hopkins Precursors Study. Arch Intern Med (2008) 1.09

Frequency of patient-physician contact in chronic kidney disease care and achievement of clinical performance targets. Int J Qual Health Care (2005) 1.08

Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. BMC Health Serv Res (2007) 1.08

Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) (2009) 1.07

Influenza transmission in a cohort of households with children: 2010-2011. PLoS One (2013) 1.07

IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol (2006) 1.07

Large arterial elasticity varies as a function of gender and racism-related vigilance in black youth. J Adolesc Health (2006) 1.06

Randomized controlled trials in nephrology: state of the evidence and critiquing the evidence. Adv Chronic Kidney Dis (2012) 1.04

Blood pressure in young adulthood and the risk of type 2 diabetes in middle age. Diabetes Care (2003) 1.03

Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. J Biomed Sci (2005) 1.02

A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension. Postgrad Med (2011) 1.01